- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03427138
Training Early Social Language in Autism (TESLA)
Investigating the Mirror Neuron System in Autism Spectrum Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The mirror neuron system (MNS) broadly refers to a network of brain regions that responds both when a person performs an action and when that person observes someone else performing the same action. This system emerges in infancy and develops over time to support more complex social abilities. It has been hypothesized that autism involves fundamental impairments to the MNS, which can explain the deficits in joint attention, imitation, communication and social cognition.
This study investigates the MNS in 100 toddlers and preschoolers recently diagnosed with autism or with a suspected diagnosis of autism. First, children with (suspected) autism complete a battery of behavioral measures and MNS activity will be assessed using electrophysiology (EEG; event-related potentials) while the child participates in specific tasks. Then, the children with (suspected) autism will be randomly assigned to one of two behavioral intervention programs (i.e., targeted joint attention intervention or parent education intervention) that will be carried out by interventionists and parents for 10-12 weeks. At the end of the intervention, these children will be re-evaluated on behavioral tasks and EEG to investigate changes as a result of the intervention.
The investigators hypothesize that the joint attention intervention will lead to significant changes on both the neural and behavioral measures of MNS functioning.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Boston University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children between the ages of 18 and 59 months with a confirmed or suspected DSM5 diagnosis of autism spectrum disorder
- The included parents or guardians are required to be the primary caregivers of these children
- Families must speak English in the home at least 75% of the time.
Exclusion Criteria:
- Seizure disorder (may influence EEG data)
- Gestational age <32 weeks
- History of serious head trauma
- Genetic syndrome (e.g., fragile X syndrome)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Jasper
JASPER (Joint Attention Symbolic Play Engagement Regulation) is a targeted intervention that focusses on early communication skills.
|
Families in the joint attention intervention will receive 10 weeks of the JASPER (Joint Attention Symbolic Play Engagement Regulation) protocol.
JASPER is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari at the Center for Autism Research and Treatment, at University of California, Los Angeles.
Our research staff will be trained on the specific techniques of JASPER guided by Connie Kasari (consultant on project) and her colleagues The study's intervention involves 2 days/week of 60-minute sessions with a trained experimenter (which may take place in the lab or home, depending on the needs of the family).
The primary goal for the intervention will be to increase the frequency and range/variety of joint attention and to advance the child to higher levels (e.g., from requesting to initiating joint attention acts).
|
Experimental: Parent Education
Parent education intervention focusses on parenting a child with autism.
|
Families in the parent education intervention.
Parent education will be provided in group sessions.
During the sessions information is presented about ASD, how to deal with behavioral difficulties and available services, and parents are given an opportunity to share experiences.
Parents will attend a weekly session for 10 weeks.
10 different topics will be discussed, which include: causes and symptoms of autism, diagnosis process, treatment options, enhancing communicative abilities in children with autism, emotion regulation, dealing with distress, correcting behavior difficulties, applying structure and routines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in EEG Frequency Data- Resting State
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
EEG frequency data as measured during resting state
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in EEG Frequency Data- Grasping Objects
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
EEG frequency data as measured while subjects grasps an object
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in EEG Frequency Data- Observing actions
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
EEG frequency data as measured while child observes objects grasped and pointed to by others.
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in joint attention measured with the Early Social and Communication scales (ESCS)
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
This behavioral assessment follows standardized guidelines to capture the full range of joint attention and behavior request skills (initiate and response).
A child has a higher score on the ESCS when they demonstrate behavior requests (e.g.
pointing to, or asking for, desired objects), or respond to behavior requests (e.g.
giving objects to other people) and joint attention (e.g.
three-point gaze).
In the ESCS, a higher score would indicate higher social and communication abilities.
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in play level measured with the Structured Play Assessment (SPA)
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Developed by Ungerer & Sigman (1981), this assessment evaluates the child's number and variety of functional and symbolic play acts when introduced sequentially to 5 toy sets.
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in imitation measured with the Elicited Imitation Battery (adapted from Rogers et al., 2003)
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
The child is presented with 3 manual actions (e.g., holding palm up), 3 actions on objects.
The child's movements will be coded on a 5-point scale from 0 (no movement) to 5 (imitating all the different experimenter actions).
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in language measured with the Elicitation of Language Sample Assessment-Toddler version (ELSA-T)
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
This 15-minute assessment is developed at the Center for Autism Research Excellence at Boston University.
It evaluates expressive language abilities of participants.
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Change in parent-child interactions
Time Frame: Assessment occurs at week 1, week 6, and week 12, with an intervention in weeks 2-11
|
A 10-minute play-based parent-child interaction, using a standard set of age-appropriate toys will be recorded and used as part of the child's expressive language sample.
|
Assessment occurs at week 1, week 6, and week 12, with an intervention in weeks 2-11
|
Change in predictive gaze measured with eye-tracking
Time Frame: Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
During the EEG task, eye movements are recorded to assess the child's ability to predict action outcomes.
|
Assessment occurs at week 1 and week 12, with an intervention in weeks 2-11
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Helen Tager-Flusberg, PhD, Boston University Charles River Campus
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4190E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
Study Data/Documents
-
Individual Participant Data Set
Information identifier: C2495
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Jasper
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesSimons FoundationRecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesRecruiting
-
Boston Children's HospitalCompleted
-
University of California, Los AngelesCompletedChildren at Risk for ASDUnited States
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesUniversity of Massachusetts, WorcesterRecruiting
-
Boston Children's HospitalRecruitingDown SyndromeUnited States
-
University of California, Los AngelesRecruiting
-
Vanderbilt UniversityUniversity of California, Los AngelesCompletedDown Syndrome | Language ImpairmentUnited States